Better survival seen in NSCLC patients who take beta blockers

01/15/2013 | News-Medical.Net

A new study has found beta blocker treatment was associated with better survival without distant metastases, improved disease-free survival and better overall survival among patients with non-small-cell lung cancer being treated with definitive radiotherapy compared with those who did not take beta blockers. The research appears in the Annals of Oncology.

View Full Article in:

News-Medical.Net

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Market Access Manager Electrophysiology HEOR (AEP) - 15000003NZ
Abbott
Menlo Park, CA